Article

(2021) In Silico designing and immunogenic production of the multimeric CfaB*ST, CfaE, LTB antigen as a peptide vaccine against Enterotoxigenic Escherichia coli. Microbial Pathogenesis. p. 10. ISSN 0882-4010

(2020) Clearance of Helicobacter pylori with formulation rCagA and LPS in a mouse model. Gene Reports. p. 6.

(2020) The Immunogenicity of a Novel Chimeric Hemagglutinin-Neuraminidase-Fusion Antigen from Newcastle Disease Virus by Oral Delivery of Transgenic Canola Seeds to Chickens. Molecular Biotechnology. pp. 344-354. ISSN 1073-6085

(2019) Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity. Artificial Cells Nanomedicine and Biotechnology. pp. 2593-2604. ISSN 2169-1401

(2019) Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli. Iranian Journal of Immunology. pp. 200-211. ISSN 1735-1383

(2019) Immunogenicity Evaluation of Recombinant Edible Vaccine Candidate Containing HER2-MUC1 against Breast Cancer. Iranian Journal of Allergy Asthma and Immunology. pp. 511-522. ISSN 1735-1502

(2019) Oral immunization with a plant-derived chimeric protein in mice: Toward r the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC. Immunobiology. pp. 262-269. ISSN 0171-2985

(2019) Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen. Journal of Microbiological Methods. pp. 100-107. ISSN 0167-7012

(2018) EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E-coli O157: H7. Artificial Cells Nanomedicine and Biotechnology. S1067-S1075. ISSN 2169-1401

(2018) Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice. Iranian Journal of Basic Medical Sciences. pp. 26-32. ISSN 2008-3866

(2018) Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications. Iranian Journal of Biotechnology. pp. 248-257. ISSN 1728-3043

(2018) In silico analysis of chimeric subunit vaccine containing HER-2-MUC1 against breast cancer. Indian Journal of Biotechnology. pp. 224-233. ISSN 0972-5849

(2017) Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection. Molecular Immunology. pp. 158-171. ISSN 0161-5890

(2017) A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli. Microbiology and Immunology. pp. 272-279. ISSN 0385-5600

(2017) Design and analysis of trivalent chimeric vaccine candidate against three enterotoxigenic bacteria: an in-silico approach. Minerva Biotecnologica. pp. 62-75. ISSN 1120-4826

(2017) A review on strategies for decreasing E-coli O157:H7 risk in animals. Microbial Pathogenesis. pp. 186-195. ISSN 0882-4010

(2017) A review on strategies for decreasing E. coli O157:H7 risk in animals. Microb Pathog. pp. 186-195. ISSN 0882-4010

(2016) Design and in silico analysis of pentavalent chimeric antigen against three enteropathogenic bacteria: enterotoxigenic E. coli, enterohemorragic E. coli and Shigella. Bioscience Biotechnology Research Communications. pp. 229-243. ISSN 0974-6455

(2016) Designing and Structure Evaluation of Multi-Epitope Vaccine Against ETEC and EHEC: An In Silico Approach. Protein and Peptide Letters. pp. 33-42. ISSN 0929-8665

(2016) Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins. Microbes and Infection. pp. 421-429. ISSN 1286-4579

(2016) In silico designing, cloning, and heterologous expression of novel chimeric human B lymphocyte CD20 extra loop. Tumor Biology. pp. 12547-12553. ISSN 1010-4283

(2015) Production and Characterization of New Anti-Human CD20 Monoclonal Antibody. Iranian Journal of Allergy Asthma and Immunology. pp. 502-508. ISSN 1735-1502

(2014) Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach. Biotechnology and Applied Biochemistry. pp. 517-527. ISSN 0885-4513

(2014) Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer. Tumor Biology. pp. 11489-11497. ISSN 1010-4283

(2014) Effects of missense R84Q mutation on human pyrroline-5-carboxylate synthase enzyme properties, an in-silico analysis. Journal of Applied Biotechnology Reports. pp. 11-16. ISSN 23221186 (ISSN)

(2014) In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus. International Journal of Peptide Research and Therapeutics. pp. 179-194. ISSN 1573-3149

(2014) Nanoparticles in vaccine development. Journal of Applied Biotechnology Reports. pp. 125-134. ISSN 23221186 (ISSN)

(2013) Bioactivity and immunological evaluation of LPS from different serotypes of Helicobacter pylori. Iran J Microbiol. pp. 142-6. ISSN 2008-3289 (Print) 2008-3289

(2013) Designing and production of a chimeric multi-epitope construct of CfaB, ST toxoid, CssA, CssB and LTB against enterotmdgenic E. coli. Current Opinion in Biotechnology. S106-S106. ISSN 0958-1669

(2013) In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori. Indian Journal of Human Genetics. pp. 43-53. ISSN 09716866 (ISSN)

(2012) Development of quantitative competitive PCR for determination of copy number and expression level of the synthetic glyphosate oxidoreductase gene in transgenic canola plants. Electronic Journal of Biotechnology. p. 14. ISSN 0717-3458

(2011) Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice. Plant Science. pp. 620-627. ISSN 0168-9452

(2010) Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7. Vaccine. pp. 6923-6929. ISSN 0264-410X

(2009) In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications. Theoretical Biology and Medical Modelling. p. 11. ISSN 1742-4682